$CL · COLGATE PALMOLIVE CO
Colgate-Palmolive reported Q3 2026 results with net sales of $5.369B (+4.6% YoY), GAAP EPS of $0.94 (+3%), and Base Business EPS of $0.97 (+7%). Organic sales grew 3.6%, driven by positive volume (+1.7%) and pricing (+2.0%). The company raised full-year 2026 guidance: Base Business EPS growth now 5%-7% (vs. mid-single-digit prior), gross margin now expected up (vs. roughly flat), and organic sales growth guided broadly in line with nine-month performance.
- Net sales rose 4.6% YoY to $5.369B; organic sales grew 3.6% with positive volume (+1.7%) and pricing (+2.0%).
- GAAP EPS of $0.94 (+3% YoY); Base Business EPS of $0.97 (+7% YoY).
- GAAP gross margin expanded 80 bps to 60.2%; Base Business gross margin up 90 bps to 60.3%.
- Full-year organic sales growth guidance narrowed to broadly in line with nine-month performance (vs. prior 1%-4%).
- Base Business EPS growth guidance raised to 5%-7% from prior mid-single-digit; gross margin now expected up vs. roughly flat.
Extended-hours trading shows shares at $96.90, +4.01% vs the regular-session close of $93.16, reflecting a positive reaction to the guidance raise and broad-based organic growth across all four categories and four of five divisions.
A consumer staples bellwether delivering broad-based organic growth across all four categories while raising both margin and EPS guidance signals pricing power and operational discipline in a volatile macro environment.
Colgate's 41.4% global toothpaste market share and 33.1% manual toothbrush share reinforce its dominant position in oral care. The fourth consecutive quarter of sequential worldwide volume improvement signals resilient demand in a challenged consumer staples environment.
Management flagged consumer uncertainty, ongoing macroeconomic volatility, and potential impacts from global trade relations and tariffs. North America net sales declined 1.7% with volume down 3.7%.